Mesenchymal stromal cells as a therapeutic intervention for COVID-19: a living systematic review and meta-analysis protocol
Abstract Background Mesenchymal stromal cells (MSCs) have significant immunomodulatory and tissue repair capabilities, mediated partly by conditioned media or through secreted extracellular vesicles (MSC-EVs). Infection with SARS-CoV-2 can cause mild to life-threatening illness due to activated immu...
Main Authors: | Aidan M. Kirkham, Madeline Monaghan, Adrian J. M. Bailey, Risa Shorr, Manoj M. Lalu, Dean A. Fergusson, David S. Allan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-09-01
|
Series: | Systematic Reviews |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13643-021-01803-5 |
Similar Items
-
Methods and efficacy of extracellular vesicles derived from mesenchymal stromal cells in animal models of disease: a preclinical systematic review protocol
by: Alvin Tieu, et al.
Published: (2019-12-01) -
Extracellular Vesicle-Dependent Communication Between Mesenchymal Stromal Cells and Immune Effector Cells
by: Riccardo Bazzoni, et al.
Published: (2020-11-01) -
Mesenchymal Stem/Stromal Cell-Derived Extracellular Vesicles and Their Potential as Novel Immunomodulatory Therapeutic Agents
by: Verena Börger, et al.
Published: (2017-07-01) -
Functional proteins of mesenchymal stem cell-derived extracellular vesicles
by: Guanguan Qiu, et al.
Published: (2019-11-01) -
Mesenchymal stem cell-derived extracellular vesicles affect disease outcomes via transfer of microRNAs
by: Guanguan Qiu, et al.
Published: (2018-11-01)